Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin.
DSE-BMP-0001-CIS-MA
Phase 1 other active
Quick answer
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin. for No medical condition. is a Phase 1 program (other) at Daiichi Sankyo Europe GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo Europe GmbH
- Indication
- No medical condition.
- Phase
- Phase 1
- Modality
- other
- Status
- active